Here is a breakdown of three long-term dividend stocks from a recent article. AbbVie (ABBV) has 53 years of consecutive dividend increases. The company is managing the Humira patent expiration well, with Skyrizi and Rinvoq already surpassing Humira's peak revenue. They are also expanding their immunology pipeline with a $10.9 billion acquisition of Apogee Therapeutics. Enbridge (ENB) yields around 5.6% and has raised its dividend for 31 years. The company projects 5% annual growth in cash flow and earnings. Future growth is expected to be driven by data center expansions, LNG demand, and coal-to-gas power plant conversions. Realty Income (O) is a REIT that pays monthly dividends with a 31-year streak of increases. They own over 15,500 properties, mostly in recession-resistant industries like grocery and dollar stores. The stock has historically held up well and outperformed the broader market during major downturns.